Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00328445 · ClinicalTrials.gov registry record · NA

Randomized Trial of the Positive Action Program in Hawaii Schools

A NA study of Substance Use and Violence, sponsored by National Institute on Drug Abuse (NIDA).

Completed
Registry status
NA
Development phase
2,500
Enrollment target
3
Study locations

NCT00328445 is a NA study of Substance Use and Violence that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 2,500 participants, above the 1,232-participant average among 88 other Substance Use trials with a reported enrollment target (103% higher). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00328445, a NA study of Substance Use and Violence, has completed, sponsored by National Institute on Drug Abuse (NIDA).

COMPLETED
Registry status
NA
Development phase
2,500 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to determine the effectiveness of the Positive Action program on reducing negative behaviors, increasing positive behaviors and improving academic achievement of elementary school students.

Interventions

  • BEHAVIORAL Positive Action

Study Locations (3)

Idaho

  • Positive Action, Inc. - Twin Falls

Illinois

  • University of Illinois at Chicago - Chicago

Oregon

  • Oregon State University - Corvallis

Trial Details

FieldValue
Enrollment Target 2,500 participants
Start Date 2001-04
Est. Completion 2006-06
Phase NA

What the Registry Record Tells You About NCT00328445

The ClinicalTrials.gov registry entry for NCT00328445 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,232-participant average among 88 other Substance Use trials with a reported enrollment target (103% higher). The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Substance Use appearing as the primary indexed condition, and to 1 intervention - of which Positive Action is the first listed.

NCT00328445 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Idaho, Illinois, Oregon.

Frequently Asked Questions

What is clinical trial NCT00328445 about?

NCT00328445 is a clinical study titled "Randomized Trial of the Positive Action Program in Hawaii Schools". The purpose of this study is to determine the effectiveness of the Positive Action program on reducing negative behaviors, increasing positive behaviors and improving academic achievement of elementary school students.

What is the current status of trial NCT00328445?

This trial is currently completed. It is a NA study. The enrollment target is 2,500 participants. The study started on 2001-04. Estimated completion is 2006-06.

What conditions does trial NCT00328445 study?

This clinical trial studies the following conditions: Substance Use, Violence, Academic Achievement, Character, Pro-social Behavior.

What interventions are being tested in trial NCT00328445?

The interventions under investigation include: Positive Action (BEHAVIORAL).

Who is sponsoring clinical trial NCT00328445?

This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00328445 being conducted?

This trial has 3 study locations across Idaho, Illinois, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.